SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(MARK ONE)
| [X] |
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
|
| [ ] |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission File Number: 000-08185
CHEMICAL FINANCIAL CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Michigan |
| 38-2022454 |
|
|
|
333 East Main Street |
|
|
(989) 839-5350
(Registrant's Telephone Number, Including Area Code)
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes X No
The number of shares outstanding of the Registrant's Common Stock, $1 par value, as of April 25, 2005, was 25,192,178 shares.
INDEX
CHEMICAL FINANCIAL CORPORATION
FORM 10-Q
| Page | |
|
| |
FORWARD-LOOKING STATEMENTS | 3 | |
|
|
|
PARTI. | FINANCIALINFORMATION |
|
|
|
|
Item 1. | Financial Statements (unaudited, except Consolidated |
|
|
|
|
| Consolidated Statements of Income for the Three Months Ended |
|
|
|
|
| Consolidated Statements of Financial Position as of March 31, 2005, |
|
|
|
|
| Consolidated Statements of Cash Flows for the Three Months Ended |
|
|
|
|
| Notes to Consolidated Financial Statements | 7-17 |
|
|
|
Item 2. | Management's Discussion and Analysis of Financial Condition and |
|
|
|
|
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 26 |
|
|
|
Item 4. | Controls and Procedures | 26 |
|
|
|
PARTII. | OTHERINFORMATION |
|
|
|
|
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 27 |
|
|
|
Item 6. | Exhibits | 28 |
|
| |
SIGNATURES | 29 |
FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates and projections about the financial services industry, the economy, and the Corporation itself. Words such as "anticipates," "believes," "estimates," "judgment," "expects," "forecasts," "intends," "is likely," "plans," "predicts," "projects," "should," "will" and variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, all statements under Part I, Item 3 concerning quantitative and qualitative disclosures about market risk are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions ("risk factors") that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence. Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statement s. The Corporation undertakes no obligation to update, amend or clarify forward-looking statements, whether as a result of new information, future events or otherwise.
Risk factors include, but are not limited to, changes in interest rates and interest rate relationships; demand for products and services; the degree of competition by traditional and non-traditional competitors; changes in banking laws and regulations; changes in tax laws; changes in prices, levies and assessments; the impact of technological advances and issues; governmental and regulatory policy changes; the outcomes of pending and future litigation and contingencies; trends in customer behavior as well as their ability to repay loans; changes in the local and national economy; opportunities for acquisition and the effective completion of acquisitions and integration of acquired entities; and the local and global effects of the ongoing war on terrorism and other military actions, including actions in Iraq. These are representative of the risk factors that could cause a difference between an ultimate actual outcome and a preceding forward-looking statement.
PART I. FINANCIAL INFORMATION
ITEM 1. | FINANCIAL STATEMENTS |
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
Consolidated Statements of Income (Unaudited)
| Three Months Ended |
| ||||
| 2005 |
| 2004 |
| ||
| (In thousands, except per share amounts) |
| ||||
INTEREST INCOME |
|
|
|
|
|
|
Interest and fees on loans | $ | 38,811 |
| $ | 37,478 |
|
Interest on investment securities: |
|
|
|
|
|
|
Taxable |
| 7,781 |
|
| 8,876 |
|
Tax-exempt |
| 490 |
|
| 565 |
|
Total interest on investment securities |
| 8,271 |
|
| 9,441 |
|
Interest on federal funds sold |
| 653 |
|
| 201 |
|
Interest on deposits with banks |
| 225 |
|
| 65 |
|
TOTAL INTEREST INCOME |
| 47,960 |
|
| 47,185 |
|
INTEREST EXPENSE |
|
|
|
|
|
|
Interest on deposits |
| 9,193 |
|
| 7,691 |
|
Interest on other borrowings - short-term |
| 348 |
|
| 96 |
|
Interest on Federal Home Loan Bank (FHLB) borrowings |
| 2,472 |
|
| 2,576 |
|
TOTAL INTEREST EXPENSE |
| 12,013 |
|
| 10,363 |
|
NET INTEREST INCOME |
| 35,947 |
|
| 36,822 |
|
Provision for loan losses |
| 730 |
|
| 746 |
|
NET INTEREST INCOMEafter provision for |
|
|
|
|
|
|
NONINTEREST INCOME |
|
|
|
|
|
|
Service charges on deposit accounts |
| 4,716 |
|
| 4,554 |
|
Trust and investment management services revenue |
| 2,017 |
|
| 1,909 |
|
Other charges and fees for customer services |
| 1,688 |
|
| 1,548 |
|
Mortgage banking revenue |
| 489 |
|
| 780 |
|
Investment securities gains |
| 1,089 |
|
| 983 |
|
Other |
| 181 |
|
| 188 |
|
TOTAL NONINTEREST INCOME |
| 10,180 |
|
| 9,962 |
|
OPERATING EXPENSES |
|
|
|
|
|
|
Salaries, wages and employee benefits |
| 14,580 |
|
| 14,801 |
|
Occupancy |
| 2,441 |
|
| 2,459 |
|
Equipment |
| 2,315 |
|
| 2,385 |
|
Other |
| 5,647 |
|
| 5,515 |
|
TOTAL OPERATING EXPENSES |
| 24,983 |
|
| 25,160 |
|
INCOME BEFORE INCOME TAXES |
| 20,414 |
|
| 20,878 |
|
Federal income taxes |
| 6,910 |
|
| 6,759 |
|
NET INCOME | $ | 13,504 |
| $ | 14,119 |
|
|
|
|
|
|
|
|
NET INCOME PER SHARE (Basic) | $ | 0.54 |
| $ | 0.56 |
|
(Diluted) | $ | 0.53 |
| $ | 0.56 |
|
Cash dividends per share | $ | 0.265 |
| $ | 0.252 |
|
See accompanying notes to consolidated financial statements.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
Consolidated Statements of Financial Position (In thousands, except par value)
| March 31, |
| December 31, |
| March 31, |
| |||
| (Unaudited) |
|
|
| (Unaudited) |
| |||
|
|
|
|
|
|
| |||
ASSETS |
|
|
|
|
|
| |||
Cash and demand deposits due from banks | $ | 94,135 |
| $ | 106,565 |
| $ | 106,610 |
|
Federal funds sold | 51,500 |
| 34,500 |
| 75,400 |
| |||
Interest bearing deposits with banks | 37,151 |
| 5,869 |
| 27,854 |
| |||
Investment securities: |
|
|
|
|
| ||||
Available for sale (at estimated fair value) | 740,738 |
| 716,757 |
| 840,957 |
| |||
Held to maturity (estimated fair value - $159,103 at |
|
|
|
|
|
| |||
Total investment securities | 900,205 |
| 893,274 |
| 1,010,699 |
| |||
Loans: |
|
|
|
|
| ||||
Commercial | 480,553 |
| 468,970 |
| 444,229 |
| |||
Real estate construction | 122,951 |
| 120,900 |
| 148,592 |
| |||
Real estate commercial | 696,018 |
| 697,779 |
| 640,292 |
| |||
Real estate residential | 756,468 |
| 760,834 |
| 773,195 |
| |||
Consumer | | 520,800 |
| | 537,102 |
| | 542,811 |
|
Total loans | 2,576,790 |
| 2,585,585 |
| 2,549,119 |
| |||
Less: Allowance for loan losses | | 34,171 |
| | 34,166 |
| | 33,494 |
|
Net loans | 2,542,619 |
| 2,551,419 |
| 2,515,625 |
| |||
Premises and equipment | 46,671 |
| 47,577 |
| 48,669 |
| |||
Intangible assets | 73,728 |
| 74,421 |
| 76,141 |
| |||
Other assets | | 50,881 |
| | 50,500 |
| | 49,574 |
|
TOTAL ASSETS | $ | 3,796,890 |
| $ | 3,764,125 |
| $ | 3,910,572 |
|
|
|
|
|
|
|
| |||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
| |||
Deposits: |
|
|
|
|
|
| |||
Noninterest-bearing | $ | 525,272 |
| $ | 555,287 |
| $ | 502,147 |
|
Interest-bearing | | 2,402,675 |
| | 2,308,186 |
| | 2,515,476 |
|
Total deposits |
| 2,927,947 |
|
| 2,863,473 |
|
| 3,017,623 |
|
Other borrowings - short-term | 94,445 |
| 101,834 |
| 92,002 |
| |||
Interest payable and other liabilities | 33,828 |
| 28,986 |
| 38,940 |
| |||
FHLB borrowings | | 253,979 |
| | 284,996 |
| | 292,210 |
|
Total liabilities | 3,310,199 |
| 3,279,289 |
| 3,440,775 |
| |||
Shareholders' equity: |
|
|
|
|
|
| |||
Common stock, $1 par value: |
|
|
|
|
|
| |||
Authorized - 30,000 shares |
|
|
|
|
|
| |||
Issued and outstanding - 25,185 shares at 3/31/05 |
|
|
|
|
|
| |||
Surplus | 379,149 |
| 378,694 |
| 331,868 |
| |||
Retained earnings | 87,096 |
| 80,266 |
| 102,530 |
| |||
Accumulated other comprehensive income/(loss) | | (4,739 | ) | | 707 |
| | 10,271 |
|
Total shareholders' equity | | 486,691 |
| | 484,836 |
| | 469,797 |
|
TOTAL LIABILITIES AND |
|
|
|
|
|
| |||
SHAREHOLDERS' EQUITY | $ | 3,796,890 |
| $ | 3,764,125 |
| $ | 3,910,572 |
|
See accompanying notes to consolidated financial statements.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows (Unaudited)
| Three Months Ended |
| ||||
| 2005 |
| 2004 |
| ||
| (In thousands) |
| ||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
| ||
Net income | $ | 13,504 |
| $ | 14,119 |
|
Adjustments to reconcile net income to net cash provided by |
|
|
|
|
|
|
operating activities: |
|
|
|
|
|
|
Provision for loan losses |
| 730 |
|
| 746 |
|
Gains on sales of loans |
| (270 | ) |
| (481 | ) |
Proceeds from loan sales |
| 19,420 |
|
| 37,997 |
|
Loans originated for sale |
| (23,364 | ) |
| (37,747 | ) |
Investment securities gains |
| (1,089 | ) |
| (983 | ) |
Depreciation of fixed assets |
| 1,554 |
|
| 1,762 |
|
Amortization of intangible assets |
| 800 |
|
| 851 |
|
Net amortization of investment securities |
| 1,433 |
|
| 2,519 |
|
Mortgage servicing rights impairment recovery |
| - |
|
| (100 | ) |
Net decrease in interest receivable and other assets |
| 4,131 |
|
| 2,638 |
|
Net increase in interest payable and other liabilities |
| 4,994 |
|
| 4,133 |
|
Net Cash Provided by Operating Activities |
| 21,843 |
|
| 25,454 |
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
Securities available for sale: |
|
|
|
|
|
|
Proceeds from maturities, calls and principal reductions |
| 59,840 |
|
| 44,037 |
|
Proceeds from sales |
| 57,119 |
|
| 54,827 |
|
Purchases |
| (149,522 | ) |
| (213,267 | ) |
Securities held to maturity: |
|
|
|
|
|
|
Proceeds from maturities, calls and principal reductions |
| 36,540 |
|
| 31,511 |
|
Purchases |
| (19,693 | ) |
| (8,198 | ) |
Net decrease (increase) in loans |
| 10,593 |
|
| (69,765 | ) |
Purchases of premises and equipment, net |
| (648 | ) |
| (815 | ) |
Net Cash Used in Investing Activities |
| (5,771 | ) |
| (161,670 | ) |
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
Net increase (decrease) in demand deposits, NOW accounts and |
|
|
|
|
|
|
savings accounts |
| (17,514 | ) |
| 58,478 |
|
Net increase (decrease) in certificates of deposit and other time deposits |
| 81,988 |
|
| (8,091 | ) |
Net increase (decrease) in other borrowings - short-term |
| (7,389 | ) |
| 478 |
|
Increase in FHLB borrowings |
| - |
|
| 150,000 |
|
Repayments of FHLB borrowings |
| (31,017 | ) |
| (13,163 | ) |
Cash dividends paid |
| (6,674 | ) |
| (6,338 | ) |
Proceeds from directors' stock purchase plan |
| 231 |
|
| 219 |
|
Proceeds from exercise of stock options |
| 155 |
|
| 2,306 |
|
Net Cash Provided by Financing Activities |
| 19,780 |
|
| 183,889 |
|
|
|
|
|
|
|
|
Net Increase in Cash and Cash Equivalents |
| 35,852 |
|
| 47,673 |
|
Cash and cash equivalents at beginning of year |
| 146,934 |
|
| 162,191 |
|
Cash and Cash Equivalents at End of Period | $ | 182,786 |
| $ | 209,864 |
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
Interest paid on deposits, other borrowings - short-term and FHLB borrowings | $ | 11,716 |
| $ | 10,196 |
|
Loans transferred to other real estate and repossessed assets | $ | 1,691 |
| $ | 1,721 |
|
See accompanying notes to consolidated financial statements.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
NOTE A: BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements of Chemical Financial Corporation (the "Corporation") have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial condition and results of operations of the Corporation for the periods presented. Operating results for the three months ended March 31, 2005 are not necessarily indicative of the results that may be expected for the year ending December 31, 2005. For further information, refer to the consolidated financial statements and footnotes thereto included in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2004.
Certain prior year amounts have been reclassified to place them on a basis comparable with the current period's financial statements. Such reclassifications had no impact on net income or shareholders' equity.
Income Taxes
The difference between the federal statutory income tax rate and the Corporation's effective federal income tax rate primarily is a function of the proportion of the Corporation's interest income exempt from federal taxation, nondeductible interest expense, other nondeductible expenses and tax credits.
Earnings Per Share
All earnings per share amounts have been presented to conform to the requirements of Statement of Financial Accounting Standards No. 128, "Earnings Per Share." Basic earnings per share exclude any dilutive effect of stock options. Basic earnings per share for the Corporation is computed by dividing net income by the weighted average number of common shares outstanding. Diluted earnings per share for the Corporation is computed by dividing net income by the sum of the weighted average number of common shares outstanding and the dilutive effect of outstanding employee stock options.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
Earnings Per Share (continued)
The following table summarizes the number of shares used in the numerator and denominator of the basic and diluted earnings per share computations:
| Three Months Ended |
| ||
| 2005 |
| 2004 |
|
| (In thousands) |
| ||
|
|
|
|
|
Numerator for both basic and diluted |
|
|
|
|
|
|
|
|
|
Denominator for basic earnings per share, |
|
|
|
|
average outstanding common shares | 25,183 |
| 25,086 |
|
Potential dilutive shares resulting from |
|
|
|
|
Denominator for diluted earnings per share | 25,247 |
| 25,185 |
|
Equity
In April of 2005, the Corporation's Board of Directors authorized management to purchase up to 500,000 shares of the Corporation's common stock. The repurchased shares will be available for later reissue in connection with potential future stock dividends, the Corporation's dividend reinvestment plan, employee benefit plans and other general purposes. This new authorization replaced all prior share repurchase authorizations.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
Comprehensive Income
The components of comprehensive income, net of related tax, for the three months ended March 31, 2005 and 2004 are as follows (in thousands of dollars):
| Three Months Ended |
| ||||
| 2005 |
| 2004 |
| ||
Net income | $ | 13,504 |
| $ | 14,119 |
|
|
|
|
|
|
|
|
Net unrealized gains (losses) |
|
|
|
|
|
|
on securities available for sale, |
|
|
|
|
|
|
net of tax benefit (expense) of |
|
|
|
|
|
|
$2,552 at 3/31/05 and $(98) at 3/31/04 |
| (4,739 | ) |
| 182 |
|
Reclassification adjustment |
|
|
|
|
|
|
for realized net gains |
|
|
|
|
|
|
included in net income, |
|
|
|
|
|
|
net of tax expense of $381 |
|
|
|
|
|
|
at 3/31/05 and $344 at 3/31/04 |
| (707 | ) |
| (639 | ) |
Comprehensive income | $ | 8,058 |
| $ | 13,662 |
|
The components of accumulated other comprehensive income, net of related tax, at March 31, 2005, December 31, 2004 and March 31, 2004 are as follows (in thousands of dollars):
| March 31, |
| December 31, |
| March 31, |
|
Net unrealized gains (losses) |
|
|
|
|
|
|
available for sale (net of related tax |
|
|
|
|
|
|
Operating Segment
Under the provisions of Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information," it is management's opinion that the Corporation operates in a single operating segment - commercial banking. The Corporation is a
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
Operating Segment (continued)
bank holding company that operates three commercial banks, a title insurance company and an insurance subsidiary, each as a separate subsidiary of the Corporation, as of March 31, 2005. The Corporation's commercial bank subsidiaries operate as community banks and offer a full range of commercial banking and fiduciary products and services to the residents and business customers in their geographical market areas. The products and services offered by the commercial bank subsidiaries are generally consistent throughout the Corporation. Each of the Corporation's commercial bank subsidiaries operates within the State of Michigan. The marketing of products and services throughout the Corporation's subsidiary banks is generally uniform, as many of the markets served by the subsidiaries overlap. The distribution of products and services is uniform throughout the Corporation's commercial bank subsidiaries and is achieved primarily through retail branch banking offices, automated teller machines and electroni cally accessed banking products. The commercial bank subsidiaries are state-chartered commercial banks and operate under the same banking regulations.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
Goodwill
The Corporation tested goodwill for impairment as of September 30, 2004. Based on these test results, the Corporation determined that there was no impairment of goodwill as of September 30, 2004. Goodwill was $63.3 million at March 31, 2005 and at March 31, 2004.
Other
The Corporation and its subsidiary banks are subject to certain legal actions arising in the ordinary course of business. In the opinion of management, after consultation with legal counsel, the ultimate disposition of these matters is not expected to have a material adverse effect on the consolidated income or financial position of the Corporation.
NOTE B: LOANS AND NONPERFORMING ASSETS
The following summarizes loans and nonperforming assets at the dates indicated (in thousands of dollars):
| March 31, |
| December 31, |
| March 31, | |||
Loans: |
|
|
|
|
| |||
Commercial | $ | 480,553 |
| $ | 468,970 |
| $ | 444,229 |
Real estate construction |
| 122,951 |
|
| 120,900 |
|
| 148,592 |
Real estate commercial |
| 696,018 |
|
| 697,779 |
|
| 640,292 |
Real estate residential |
| 756,468 |
|
| 760,834 |
|
| 773,195 |
Consumer |
| 520,800 |
|
| 537,102 |
|
| 542,811 |
Total Loans | $ | 2,576,790 |
| $ | 2,585,585 |
| $ | 2,549,119 |
|
|
|
|
|
|
|
|
|
Nonperforming Assets: |
|
|
|
|
|
|
|
|
Nonaccrual loans | $ | 7,823 |
| $ | 8,397 |
| $ | 5,317 |
Loans 90 days or more past due and |
|
|
|
|
|
|
|
|
still accruing interest |
| 2,914 |
|
| 1,653 |
|
| 6,559 |
Total Nonperforming Loans |
| 10,737 |
|
| 10,050 |
|
| 11,876 |
Repossessed assets acquired(1) |
| 6,544 |
|
| 6,799 |
|
| 6,294 |
Total Nonperforming Assets | $ | 17,281 |
| $ | 16,849 |
| $ | 18,170 |
(1) | Includes property acquired through foreclosure and by acceptance of a deed in lieu of foreclosure, and other property held for sale. |
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
NOTE C: ALLOWANCE FOR LOAN LOSSES
The following summarizes the changes in the allowance for loan losses (in thousands of dollars):
| Three MonthsEnded |
| ||
| 2005 |
| 2004 |
|
Allowance for Loan Losses |
|
|
|
|
Balance as of January 1 | $ 34,166 |
| $ 33,179 |
|
Provision for loan losses | 730 |
| 746 |
|
|
|
|
|
|
Gross loans charged off | (857 | ) | (945 | ) |
Gross recoveries of loans previously charged off | 132 |
| 514 |
|
Net loans charged off | (725 | ) | (431 | ) |
Balance as of end of period | $ 34,171 |
| $ 33,494 |
|
The Corporation considers all nonaccrual commercial and commercial real estate loans to be impaired loans. Impaired loans as of March 31, 2005, December 31, 2004, and March 31, 2004, were $4.3 million, $4.6 million and $4.2 million, respectively. The allowance for impaired loans was $1.1 million, $0.4 million and $1.9 million as of March 31, 2005, December 31, 2004, and March 31, 2004, respectively.
NOTE D: ACQUIRED INTANGIBLE ASSETS
The following table sets forth the carrying amount, accumulated amortization and amortization expense of acquired intangible assets (in thousands):
| March 31, 2005 |
| December 31, 2004 |
| March 31, 2004 | |||||||||||||||
| Carrying |
| Accumulated |
| Carrying |
| Accumulated |
| Other |
| Carrying |
| Accumulated | |||||||
Core deposit |
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
intangibles | $6,962 |
|
| $12,307 |
|
| $7,507 |
|
| $11,762 |
|
| $ 0 |
|
| $8,991 |
|
| $10,278 |
|
Other | 362 |
|
| 503 |
|
| 424 |
|
| 356 |
|
| 85 |
|
| 732 |
|
| 133 |
|
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
NOTE D: ACQUIRED INTANGIBLE ASSETS (continued)
Amortization expense for the:
| Quarter ended March 31, 2005 |
| $ 607 |
|
|
|
|
|
|
| Quarter ended March 31, 2004 |
| 566 |
|
|
|
|
|
|
| Year ended December 31, 2004 |
| 2,273 |
|
Estimated amortization expense for the years ending December 31:
| 2005 | $2,181 |
|
| 2006 | 1,886 |
|
| 2007 | 1,635 |
|
| 2008 | 1,292 |
|
| 2009 and thereafter | 936 |
|
NOTE E: STOCK OPTIONS
The Corporation periodically grants stock options for a fixed number of shares with an exercise price equal to the market value of the shares on the date of grant. In accordance with Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation" (SFAS No. 123), the Corporation accounts for stock option grants under the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" (APB 25). Under APB 25, because the exercise prices of the Corporation's stock options equal the market prices of the underlying stock at the dates of grant, no compensation expense is recognized at the date of grant.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
NOTE E: STOCK OPTIONS (continued)
If the Corporation had elected to recognize compensation cost in the three months ended March 31, 2005 and 2004, based on the fair value of the options granted at the grant dates, net income and earnings per share would have been reduced to the pro forma amounts indicated below (in thousands, except per share amounts):
| Three Months Ended |
| ||||
2005 | 2004 | |||||
Net income - as reported | $ | 13,504 | $ | 14,119 | ||
Deduct: Total stock-based employee | ||||||
fair value based method for all awards, | ||||||
net of related tax effects | | (262 | ) | | (131 | ) |
Net income - pro forma | $ | 13,242 | $ | 13,988 | ||
Basic earnings per share - as reported | $ | 0.54 | $ | 0.56 | ||
Basic earnings per share - pro forma |
| 0.53 |
|
| 0.56 |
|
Diluted earnings per share - as reported | 0.53 | 0.56 | ||||
Diluted earnings per share - pro forma | 0.52 | 0.56 |
NOTE F: FINANCIAL GUARANTEES
In the normal course of business, the Corporation is a party to financial instruments containing credit risk that are not required to be reflected in the consolidated statements of financial position. For the Corporation, these financial instruments are financial and performance standby letters of credit. The Corporation has risk management policies to identify, monitor and limit exposure to credit risk. To mitigate credit risk for these financial guarantees, the Corporation generally determines the need for specific covenant, guarantee and collateral requirements on a case-by-case basis, depending on the nature of the financial instrument and the customer's creditworthiness. At March 31, 2005, the Corporation had $25.0 million of outstanding financial and performance standby letters of credit which expire in five years or less. The majority of these standby letters of credit are collateralized. The amount of a potential liability arising from these standby letters of credit is considered immaterial to the financial statements as a whole.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
NOTE G: EMPLOYEE BENEFIT PLANS
The components of net periodic benefit cost for the Corporation's qualified pension plan and non-qualified postretirement benefit plan are as follows:
(in thousands) | Defined Benefit |
| Postretirement |
| ||||||||
Three Months Ended March 31, | 2005 |
| 2004 |
| 2005 |
| 2004 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost | $ | 1,220 |
| $ | 1,086 |
| $ | - |
| $ | 7 |
|
Interest cost |
| 1,068 |
|
| 1,034 |
|
| 71 |
|
| 79 |
|
Expected return on plan assets |
| (1,461 | ) |
| (1,356 | ) |
| - |
|
| - |
|
Amortization of prior service cost |
| (6 | ) |
| (9 | ) |
| (81 | ) |
| (81 | ) |
Amortization of unrecognized net loss |
| 118 |
|
| 94 |
|
| 17 |
|
| 81 |
|
Net periodic benefit cost | $ | 939 |
| $ | 849 |
| $ | 7 |
| $ | 86 |
|
For further information on the Corporation's employee benefit plans, refer to Note H to the consolidated financial statements incorporated in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2004.
NOTE H: PENDING ACCOUNTING PRONOUNCEMENTS
In March 2004, the Emerging Issues Task Force (EITF), a standard setting body working under the Financial Accounting Standards Board (FASB), reached a revised consensus on EITF Issue No. 03-1, "The Meaning of Other than Temporary Impairment and its Application to Certain Investments." The revised consensus contained a model to be used in determining whether an investment is other-than-temporarily impaired and guidance on the recognition of other-than-temporary impairment. The other-than-temporary impairment evaluation and recognition guidance was to be effective on July 1, 2004. In September 2004, the FASB issued FASB Staff Position (FSP), EITF Issue No. 03-1-a, which delayed the effective date of the guidance in EITF Issue No. 03-1 related to the evaluation and recognition of impairment on investments. In September 2004, the FASB also issued a proposed FSP which would, if adopted, revise the other-than-temporary impairment guidance contained in EITF Issue No. 03-1. The FASB had not issued final auth oritative guidance on this topic at March 31, 2005. When this occurs, the effect of this guidance on the Corporation's financial condition and results of operations, if any, will be determined.
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
NOTE H: PENDING ACCOUNTING PRONOUNCEMENTS (continued)
On December 16, 2004, the FASB issued Statement of Financial Accounting Standards No. 123(R), "Share-Based Payment" (SFAS No. 123(R)), which is a revision of SFAS No. 123, "Accounting for Stock-Based Compensation." SFAS No. 123(R) supersedes APB 25 and amends Statement of Financial Accounting Standards No. 95, "Statement of Cash Flows." Generally, the approach in SFAS No. 123(R) is similar to the approach described in SFAS No. 123. However, SFAS No. 123(R) requires all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Pro forma disclosure is no longer an alternative.
On April 14, 2005, the SEC deferred the required implementation date for SFAS No. 123(R) to the beginning of the first fiscal year beginning after June 15, 2005. The Corporation expects to adopt SFAS No. 123(R) on January 1, 2006.
SFAS No. 123(R) permits public companies to adopt its requirements using one of two methods:
1. | A "modified prospective" method in which compensation cost is recognized beginning with the effective date (a) based on the requirements of SFAS No. 123(R) for all share-based payments granted after the effective date and (b) based on the requirements of SFAS No. 123 for all awards granted to employees prior to the effective date of SFAS No. 123(R) that remain unvested on the effective date. |
|
|
2. | A "modified retrospective" method which includes the requirements of the modified prospective method described above, but also permits entities to restate based on the amounts previously disclosed under SFAS No. 123 for purposes of pro forma disclosures either (a) all prior periods presented or (b) prior interim periods of the year of adoption. |
As of March 31, 2005, the Corporation had not determined the method or assumptions that it will use to adopt SFAS No. 123(R) on January 1, 2006.
As permitted by SFAS No. 123, the Corporation currently accounts for share-based payments to employees using APB 25's intrinsic value method and, as such, does not recognize compensation cost for employee stock options. Accordingly, the adoption of SFAS No. 123(R)'s fair value method will have an impact on the Corporation's consolidated results of operations, although it will have no impact on its overall financial position. The impact of adoption of SFAS No. 123(R) cannot be predicted at this time because it will depend on levels of share-based payments granted in the future. However, had the Corporation adopted SFAS No. 123(R) in prior periods, the impact of that standard would have approximated the impact of SFAS No. 123 as described in the disclosure of
CHEMICAL FINANCIAL CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
March 31, 2005
NOTE H: PENDING ACCOUNTING PRONOUNCEMENTS (continued)
pro forma net income and earnings per share in Note O to the annual consolidated financial statements and Note E herein. SFAS No. 123(R) also requires the benefit of tax deductions in excess of recognized compensation cost to be reported as a financing cash flow, rather than as an operating cash flow as required under current literature. This requirement will reduce net operating cash flows and increase net financing cash flows in periods after adoption. While the Corporation cannot estimate what those amounts will be in the future (because they depend on, among other things, when employees exercise stock options), the amount of operating cash flows recognized in prior annual periods for such excess tax deductions were $609,000, $504,000, and $56,000 in the years ended December 31, 2004, 2003 and 2002, respectively.
ITEM 2. | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
The following is management's discussion and analysis of certain significant factors that have affected the Corporation's financial condition and results of operations during the periods included in the consolidated financial statements included in this filing.
SUMMARY
The Corporation's net income was $13.5 million in the first quarter of 2005, down 4.4% from net income of $14.1 million in the first quarter of 2004. Diluted earnings per share were $0.53 in the first quarter of 2005, down 5.4% from diluted earnings per share of $0.56 in the first quarter of 2004.
Return on average assets in the first quarter of 2005 was 1.43%, compared to 1.46% in the first quarter of 2004. Return on average equity in the first quarter of 2005 was 11.2%, compared to 12.3% in the first quarter of 2004.
Total assets were $3.80 billion as of March 31, 2005, up $32.8 million, or 0.9%, from total assets of $3.76 billion as of December 31, 2004.
Total loans decreased $8.8 million, or 0.3%, from December 31, 2004 to $2.58 billion as of March 31, 2005. The decrease in total loans was primarily due to a decline in consumer and real estate loans, excluding real estate construction loans.
Shareholders' equity increased $1.9 million, or 0.4%, from December 31, 2004 to $486.7 million as of March 31, 2005, or $19.32 per share, representing 12.8% of total assets. The increase was primarily attributable to retained net income offset by a change in the net unrealized gain on investment securities classified as available for sale to a net unrealized loss.
RESULTS OF OPERATIONS
Net Interest Income
The Corporation's net interest income in the first quarter of 2005 was $35.9 million, a $0.9 million or 2.4% decrease from the $36.8 million recorded in the first quarter of 2004. The decrease was primarily attributable to an increase in interest rates paid on deposits that more than offset the increase in the interest earned on the Corporation's interest-earning assets, and a slight decrease in average interest-earning assets. The average interest cost of deposits increased 34 basis points, while the average yield on interest-earning assets increased 20 basis points, between the first quarter of 2004 and the first quarter of 2005. The average cost of deposits was 1.57% in the first quarter of 2005, compared to 1.23% in the first quarter of 2004. In comparison, the average yield on interest-earning assets was 5.47% in the first quarter of 2005, compared to 5.27% in the first quarter of 2004. Average interest-earning assets of $3.586 billion in the first quarter of 2005 were down $48.1 million or 1.32% fro m the first quarter of 2004. The decrease primarily resulted from a decrease in total deposits, including brokered deposits. The net interest margin was 4.11% in the first quarter of 2005, compared to 4.12% in the first quarter of 2004 and 4.18% in the fourth quarter of 2004.
The Corporation's net interest income in the first quarter of 2005 was $1.3 million or 3.5% lower than in the fourth quarter of 2004, as the Corporation's balance sheet became liability sensitive during the first quarter of 2005. Short-term interest rates rose steadily during the nine months ended March 31, 2005, with the Federal Open Market Committee raising the federal funds rate seven times, or one hundred and seventy-five basis points, during this period. The majority of the Corporation's deposits have no defined maturity and reprice at management's discretion. However, the Corporation must increase interest rates on these deposits in a rising interest rate environment to remain competitive within its markets. Competition remains strong for customer deposit accounts and, with short-term interest rates expected to increase throughout the remainder of 2005, the Corporation anticipates a continued gradual increase in the average cost of its deposit liabilities. In addition, the economy in the State of Michigan, particularly in the smaller markets serviced by the Corporation, slowed during the second half of 2004 and did not rebound during the first quarter of 2005. The sluggish economy during the first quarter of 2005 hampered the Corporation's ability to increase its loan portfolio and its efforts to increase pricing on new fixed rate loans in line with the overall increase in market interest rates. These items, coupled with rising deposit interest rates, resulted in a reduction in net interest income during the first quarter of 2005, compared to both the first and fourth quarters of 2004. The Corporation's ability to increase net interest income during the remainder of 2005 will be contingent on a number of factors, including but not limited to, the shape of the interest yield curve, the state of the economic climate in the markets that the Corporation serves, the degree of competition from other financial institutions for both loan customers and deposit accounts and the Corporation's ability to attr act new customers to its subsidiary banks from competitor financial institutions.
Provision for Loan Losses
The provision for loan losses ("provision") is the amount added to the allowance for loan losses ("allowance") to absorb loan losses in the loan portfolio. The allowance provides for probable losses that have been identified with specific customer relationships and for probable losses believed to be inherent in the remainder of the loan portfolio but that have not been specifically identified. The allowance is comprised of specific allowances (assessed for loans that have known credit weaknesses), general allowances based on assigned risk ratings and an unallocated allowance for imprecision in the subjective nature of the specific and general allowance methodology. Management evaluates the allowance on a quarterly basis to ensure the level is adequate to absorb losses inherent in the loan portfolio. This evaluation is based on a review of the loan portfolio, both individually and by category, and includes consideration of changes in the mix and volume of the loan portfolio, actual loan loss experience, th e financial condition of the borrowers, industry and geographical exposures within the portfolio, economic conditions and employment levels of the Corporation's local markets, and other factors affecting business sectors.
The provision for loan losses was $0.73 million in the first quarter of 2005 and $0.75 million in the first quarter of 2004. Net loan charge-offs were $0.73 million in the first quarter of 2005 and $0.43 million in the first quarter of 2004.
Noninterest Income
Noninterest income increased $0.22 million, or 2.2%, in the first quarter of 2005, compared to the first quarter of 2004. The Corporation experienced slight increases in a number of noninterest income categories, including trust and investment management services revenue, service charges on deposit accounts, ATM and debit card revenue, and investment securities gains. These increases
were mostly offset by a continued reduction in mortgage banking revenue and related title insurance agency commissions. Investment securities gains of $1.09 million in the first quarter of 2005 included $0.85 million attributable to the sale of one common stock equity security owned by the parent company. Investment securities gains of $0.98 million in the first quarter of 2004 included $0.61 million of investment securities gains attributable to the sale of common stock equity securities owned by the parent company. The parent company did not hold any remaining common stock equity securities as of March 31, 2005.
Operating Expenses
Total operating expenses decreased $0.18 million, or 0.7%, in the first quarter of 2005, compared to the first quarter of 2004. The Corporation was successful in controlling the growth of operating expenses by reducing the overall full-time equivalent staff by 48 employees, or 3.3% during the twelve months ended March 31, 2005. This reduction was achieved through normal attrition. The Corporation had 1,398 employees on a full-time equivalent basis as of March 31, 2005.
Income Tax Expense
The Corporation's effective federal income tax rate was 33.9% in the first quarter of 2005 compared to 32.4% in the first quarter of 2004. The difference between the federal statutory income tax rate and the Corporation's effective federal income tax rate primarily is a function of the proportion of the Corporation's interest income exempt from federal taxation, nondeductible interest expense, other nondeductible expenses and tax credits. In addition, during the first quarter of 2004, the Corporation used a capital loss carryover to offset the gain of investment securities sold by the parent company, reducing the federal income tax provision $0.19 million in that quarter.
BALANCE SHEET CHANGES
Total Assets
Total assets were $3.80 billion as of March 31, 2005, up $32.8 million, or 0.9%, from total assets of $3.76 billion as of December 31, 2004.
Loans
The Corporation's philosophy is such that it will not compromise on loan quality and generally does not make loans outside its banking markets to grow its loan portfolio. In addition, the Corporation generally does not participate in syndicated loans, which is a method utilized by many financial institutions to increase the size of their loan portfolios. The Corporation's loan portfolio is generally diversified geographically within the State of Michigan, as well as along industry lines and, therefore, the Corporation believes that its loan portfolio is reasonably sheltered from material adverse local economic impact.
Total loans as of March 31, 2005 were $2.58 billion, down $8.8 million or 0.3%, compared to $2.59 billion as of December 31, 2004. Loan demand has notably declined during the six months ended March 31, 2005 as the economic climate in the State of Michigan has slowed. Concurrently, loan interest rates are lower than expected in this interest rate environment as the competition for loan volume remains strong in the Corporation's local markets.
Residential real estate loans decreased $4.4 million, or 0.6%, from December 31, 2004 to $756.5 million as of March 31, 2005. Residential real estate loans represented 29.4% of the Corporation's loan portfolio as of March 31, 2005 and December 31, 2004. The Corporation's residential real estate loans primarily consist of one- to four-family residential loans with original terms of fifteen years or less. The loan-to-value ratio at time of origination is generally 80% or less. Loans with more than an 80% loan-to-value ratio generally require private mortgage insurance or are sold in the secondary market. During 2004 and the first quarter of 2005, fixed rate mortgages with terms of fifteen or more years were generally sold in the secondary market.
Real estate construction loans increased $2.1 million, or 1.7%, from December 31, 2004 to $123.0 million as of March 31, 2005. Real estate construction loans represented 4.8% and 4.7% of the Corporation's loan portfolio as of March 31, 2005 and December 31, 2004, respectively. Construction lending is generally considered to involve a higher degree of risk than one- to four-family residential lending because of the uncertainties of construction, including the possibility of costs exceeding the initial estimates and the need to obtain a tenant or purchaser of the property if it will not be owner-occupied. The Corporation generally attempts to mitigate the risks associated with construction lending by, among other things, lending primarily in its market area, using conservative underwriting guidelines, and closely monitoring the construction process.
Commercial loans increased $11.6 million, or 2.5%, from December 31, 2004 to $480.6 million as of March 31, 2005. The increase in commercial loans was due to a continued emphasis on this type of lending. Commercial loans represented 18.6% and 18.1% of the Corporation's loan portfolio as of March 31, 2005 and December 31, 2004, respectively.
Commercial real estate loans decreased $1.8 million, or 0.3%, from December 31, 2004 to $696.0 million as of March 31, 2005. Commercial real estate loans represented 27.0% of the Corporation's loan portfolio as of March 31, 2005 and December 31, 2004.
Commercial lending and commercial real estate lending are generally considered to involve a higher degree of risk than one- to four-family residential lending. Such lending typically involves large loan balances concentrated in a single borrower for rental or business properties or for the operation of a business. In addition, the payment experience on loans secured by income-producing properties is typically dependent on the success of the operation of the related project and thus is typically affected by adverse conditions in the real estate market and in the economy. The Corporation generally attempts to mitigate the risks associated with commercial lending by, among other things, lending primarily in its market area and using conservative loan-to-value ratios in the underwriting process.
Consumer loans decreased $16.3 million, or 3.0%, from December 31, 2004 to $520.8 million as of March 31, 2005. Consumer loans represented 20.2% and 20.8% of the Corporation's loan portfolio as of March 31, 2005 and December 31, 2004, respectively.
Consumer loans generally have shorter terms than mortgage loans but generally involve more credit risk than one- to four-family residential lending because of the type and nature of the collateral. Collateral values, particularly those of automobiles, are negatively impacted by many factors, such as new car promotions, vehicle condition and economic conditions. Consumer lending collections are dependent on the borrower's continuing financial stability, and thus are more likely to be negatively affected by adverse personal situations.
Nonperforming loans consist of loans which are past due as to principal or interest by 90 days or more and are still accruing interest, loans for which the accrual of interest has been discontinued, and other loans which have been restructured to less than market terms due to a serious weakening of the borrower's financial condition. Nonperforming loans were $10.7 million as of March 31, 2005 and $10.1 million as of December 31, 2004, and represented 0.42% and 0.39% of total loans, respectively. The increase in nonperforming loans was due to an increase in loans past due 90 days or more.
A loan is considered impaired when management determines it is probable that all of the principal and interest due under the contractual terms of the loan will not be collected. In most instances, the impairment is measured based on the fair market value of the underlying collateral. Impairment may also be measured based on the present value of expected future cash flows discounted at the loan's effective interest rate. A portion of the allowance for loan losses may be allocated to impaired loans. The Corporation has taken the position that all nonaccrual commercial and commercial real estate loans are considered impaired loans.
Impaired loans totaled $4.3 million as of March 31, 2005 and $4.6 million as of December 31, 2004. After analyzing the various components of the customer relationships and evaluating the underlying collateral of impaired loans, the allowance for loan losses allocated to impaired loans was $1.1 million at March 31, 2005 and $0.4 million at December 31, 2004. The process of measuring impaired loans and the allocation of the allowance for loan losses requires judgment and estimation. The eventual outcome may differ from the estimates used on these loans.
The allowance for loan losses was $34.2 million at March 31, 2005 and represented 1.33% of total loans, compared to $34.2 million, or 1.32% of total loans at December 31, 2004.
LIQUIDITY
The maintenance of an adequate level of liquidity is necessary to ensure that sufficient funds are available to meet customers' loan demands and deposit withdrawals and to capitalize on opportunities for business expansion. The banking subsidiaries' primary liquidity sources consist of investment securities, those designated as held to maturity maturing within one year and those classified as available for sale, loan payments, FHLB borrowings and federal funds sold.
The Corporation's total loan to deposit ratio as of March 31, 2005 and December 31, 2004 was 88.0% and 90.3%, respectively.
The Corporation has contractual obligations that require future cash payments. The most significant of these is FHLB borrowings. The following table shows scheduled principal reductions on FHLB borrowings (in thousands):
| April 1, 2005 - December 31, 2005 | $ | 92,215 |
|
| 2006 |
| 78,692 |
|
| 2007 |
| 10,023 |
|
| 2008 |
| 30,024 |
|
| 2009 |
| 25 |
|
| Thereafter |
| 43,000 |
|
| Total | $ | 253,979 |
|
The Corporation increased its FHLB borrowings in January 2004 by $150 million. The proceeds were invested approximately equally in five and seven year balloon type mortgage-backed securities. These borrowings primarily mature in 2005 and 2006. The Corporation has investment securities maturing during 2005 and 2006 that have been identified as available to fund the FHLB scheduled principal payments. At March 31, 2005, $125 million of the January 2004 borrowing was outstanding.
The FHLB borrowings are collateralized by a blanket lien on qualified one- to four-family residential mortgage loans. The carrying value of these mortgage loans was $694 million, which represented a total borrowing capacity based on existing collateral of $479 million as of March 31, 2005. Therefore, the Corporation's additional borrowing availability through the FHLB at March 31, 2005 under the blanket lien agreement was $225 million. The FHLB's willingness to lend up to the total borrowing capacity is contingent upon, but not limited to, the acceptability of the Corporation's three subsidiary banks' financial condition to the FHLB at the time of each credit request, as well as the Corporation's three subsidiary banks' compliance with all applicable collateral requirements, regulations, laws, and FHLB policies. The Corporation has the option to pledge additional qualified loans and investment securities to potentially create additional borrowing availability with the FHLB.
The Corporation has various commitments that may impact liquidity. The following table summarizes the Corporation's commitments and expected expiration dates by period at March 31, 2005. Since many of these commitments historically have expired without being drawn upon, the total amount of these commitments does not necessarily represent future cash requirements of the Corporation.
| March 31, 2005 | ||||
|
|
|
| More |
|
Unused commitments to extend credit | $174,265 | $21,611 | $61,608 | $19,258 | $276,742 |
Undisbursed loans | 123,415 | - | - | - | 123,415 |
Standby letters of credit | 11,980 | 9,699 | 3,351 | - | 25,030 |
Total commitments | $309,660 | $31,310 | $64,959 | $19,258 | $425,187 |
CAPITAL RESOURCES
As of March 31, 2005, shareholders' equity was $486.7 million, compared to $484.8 million as of December 31, 2004, resulting in an increase of $1.9 million, or 0.4%. Shareholders' equity as a percentage of total assets was 12.8% as of March 31, 2005 and 12.9% as of December 31, 2004.
A statement of changes in shareholders' equity covering the three-month periods ended March 31, 2005 and March 31, 2004 follows (in thousands):
Three Months Ended | ||||||
2005 | 2004 | |||||
Total shareholders' equity as of January 1 | $ | 484,836 | $ | 458,049 | ||
Comprehensive income: | ||||||
Net income | 13,504 | 14,119 | ||||
Change in unrealized net gains on securities | ||||||
available for sale, net of tax | | (5,446 | ) | | (457 | ) |
Total comprehensive income | 8,058 | 13,662 | ||||
Cash dividends paid | (6,674 | ) | (6,338 | ) | ||
Shares issued from stock option and other plans | | 471 | | 4,424 | ||
Total shareholders' equity as of end of period | $ | 486,691 | $ | 469,797 |
The following table represents the Corporation's regulatory capital ratios as of March 31, 2005:
|
|
| Tier 1 |
| Total |
| |||
|
|
|
|
|
|
| |||
Chemical Financial Corporation - actual ratio | 11.2 | % |
| 16.5 | % |
| 17.7 | % |
|
Regulatory minimum ratio | 3.0 |
|
| 4.0 |
|
| 8.0 |
|
|
Ratio considered "well capitalized" by |
|
|
|
|
|
|
|
|
|
The Corporation's Tier 1 and Total capital ratios under the risk-based capital measure at March 31, 2005 exceed the regulatory agencies ratios to be considered "well capitalized" partially due to the Corporation holding $107 million in investment securities and other assets which are assigned a 0% risk rating; $918 million in assets, primarily investment securities, which are assigned a 20% risk rating; and $905 million in residential real estate mortgages and other assets which are assigned a 50% risk rating. These three risk ratings (0%, 20% and 50%) represented 49% of the Corporation's total risk-based assets (including off-balance sheet items) as of March 31, 2005.
The following table shows stock repurchase activity by the Corporation during the periods indicated:
| Three Months Ended March 31 |
| ||
| 2005 |
| 2004 |
|
|
|
|
|
|
Number of shares repurchased | 7,061 |
| 3,180 |
|
Average price of shares repurchased | $ 38.28 |
| $ 36.72 |
|
All of the shares included in the table above were repurchased by the Corporation from officers and employees in payment of the exercise price and/or required tax withholding upon the exercise of stock options.
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
The information concerning quantitative and qualitative disclosures about market risk contained in the discussion regarding interest rate risk and sensitivity under the captions "Liquidity Risk" and "Market Risk" on pages 18 through 23 of the Corporation's Annual Report to Shareholders for the year ended December 31, 2004 is herein incorporated by reference. Such Annual Report was previously filed as Exhibit 13 to the Corporation's Annual Report on Form 10-K for the year ended December 31, 2004.
The Corporation does not believe that there has been a material change in the nature or categories of the Corporation's primary market risk exposure, or the particular markets that present the primary risk of loss to the Corporation. As of the date of this report, the Corporation does not know of or expect there to be any material change in the general nature of its primary market risk exposure in the near term. The methods by which the Corporation manages its primary market risk exposure, as described in the sections of its Annual Report to Shareholders incorporated by reference in response to this item, have not changed materially during the current year. As of the date of this report, the Corporation does not expect to make material changes in those methods in the near term. The Corporation may change those methods in the future to adapt to changes in circumstances or to implement new techniques.
The Corporation's market risk exposure is mainly comprised of its vulnerability to interest rate risk. Prevailing interest rates and interest rate relationships are primarily determined by market factors that are beyond the Corporation's control. All information provided in response to this item consists of forward-looking statements. Reference is made to the section captioned "Forward-Looking Statements" in this report for a discussion of the limitations on the Corporation's responsibility for such statements. In this discussion, "near term" means a period of one year following the date of the most recent consolidated statement of financial position contained in this report.
ITEM 4. | CONTROLS AND PROCEDURES |
An evaluation was performed under the supervision and with the participation of the Corporation's management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Corporation's disclosure controls and procedures. Based on and as of the time of that evaluation, the Corporation's management, including the Chief Executive Officer and Chief Financial Officer, concluded that the Corporation's disclosure controls and procedures were effective as of the end of the period covered by this report. There was no change in the Corporation's internal control over financial reporting that occurred during the three months ended March 31, 2005 that has materially affected, or that is reasonably likely to materially affect, the Corporation's internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
The following table provides the purchases of equity securities by the Corporation during the periods indicated:
Issuer Purchases of Equity Securities
|
|
| Total Number of | Maximum | ||||
|
|
|
|
| ||||
January 1-31, 2005 | 6,743 |
| $38.45 |
| - |
| - |
|
|
|
|
|
|
|
|
|
|
February 1-28, 2005 | 318 |
| 34.50 |
| - |
| - |
|
|
|
|
|
|
|
|
|
|
March 1-31, 2005 | - |
| - |
| - |
| - |
|
|
|
|
|
|
|
|
|
|
Total | 7,061 |
| $38.28 |
| - |
| - |
|
* | All shares purchased during the three months ended March 31, 2005 were in connection with employee stock option exercises in satisfaction of payment of the exercise price or tax withholding obligations. |
In April of 2005, the Corporation's Board of Directors authorized management to purchase up to 500,000 shares of the Corporation's common stock. The repurchased shares will be available for later reissue in connection with potential future stock dividends, the Corporation's dividend reinvestment plan, employee benefit plans and other general corporate purposes. This new authorization replaced all prior share repurchase authorizations.
ITEM 6. | EXHIBITS |
Exhibits. The following exhibits are filed as part of this report on Form 10-Q:
| Exhibit |
|
|
|
|
|
|
| 3.1 |
| RestatedArticlesofIncorporation. Previously filed as Exhibit 4.1 to the Corporation's Registration Statement on Form S-8 filed with the Commission on March 2, 2001. Here incorporated by reference. |
|
|
|
|
| 3.2 |
| RestatedBylaws. Previously filed as Exhibit 3.2 to the Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. Here incorporated by reference. |
|
|
|
|
| 31.1 |
| Certification. Certification of President and Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
| 31.2 |
| Certification. Certification of Executive Vice President, Chief Financial Officer and Treasurer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
|
| 32.1 |
| Certificationpursuantto18U.S.C.§1350. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CHEMICAL FINANCIAL CORPORATION |
|
|
|
|
Date: May 5, 2005 | By: /s/ David B. Ramaker |
| David B. Ramaker |
|
|
|
|
Date: May 5, 2005 | By: /s/ Lori A. Gwizdala |
| Lori A. Gwizdala |
EXHIBIT INDEX
Exhibit |
|
|
|
|
|
3.1 |
| RestatedArticlesofIncorporation. Previously filed as Exhibit 4.1 to the Corporation's Registration Statement on Form S-8 filed with the Commission on March 2, 2001. Here incorporated by reference. |
|
|
|
3.2 |
| RestatedBylaws. Previously filed as Exhibit 3.2 to the Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2004. Here incorporated by reference. |
|
|
|
31.1 |
| Certification. Certification of President and Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2 |
| Certification. Certification of Executive Vice President, Chief Financial Officer and Treasurer under Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1 |
| Certificationpursuantto18U.S.C.§1350. |